You searched for Humanized antibody - Page 10 of 44

sanofi biomunex cancer therapy bispecific antibodies 1

News and Trends 15 Jan 2019

Sanofi Obtains License for French Company’s Antibody Engineering Platform

…a trend of big pharma companies paying for multi-specific antibody technology from smaller partners. Last year, Takeda and the US company Denali Therapeutics began using bispecific antibody technology from UK-based…

January 15, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 6 Nov 2017

German Biotech Teams Up with BioNTech to Boost Antibody Development

MAB Discovery and BioNTech are working together to push through the development of new antibody therapeutics using MAB’s technology platform. MAB Discovery creates monoclonal antibodies by stimulating natural antibody maturation…

November 6, 2017 - 1 minutemin - By Alex Dale

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…core focus is the discovery and development of new antibody-based drugs for the treatment of cancer, immune disorders, and inflammatory diseases. Novimmune’s innovation lies in their monoclonal and bispecific antibody…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

In Depth 30 Apr 2025

The future of NSCLC treatment: what’s in store for the therapeutic space?

…AstraZeneca is also developing datopotamab deruxtecan, which is an antibody-drug conjugate (ADC) for locally advanced NSCLC. ADCs are composed of a monoclonal antibody that fits into tumor antigens when binding…

April 30, 2025 - 12 minutesmins - By Roohi Mariam Peter

covid 19 vaccines adenovirus adenoviral vector

News and Trends 8 Jun 2022

New COVID antibody cocktail developed

…in live virus neutralization assays. The cocktail and each antibody also outperformed other monoclonal treatments currently approved or authorized by the FDA and EMA, particularly against Omicron. “Antibody cocktails will…

June 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 22 Nov 2019

ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV

…of Health, US. ViiV Healthcare’s majority shareholder, the pharma company GSK, licensed the antibody from the US organization, and ViiV Healthcare will launch a phase IIa trial of the antibody…

November 22, 2019 - 2 minutesmins - By Jonathan Smith

antibiotic antibody staphylococcus symphogen 1

More News! 30 Nov 2017

Cha-Ching! Danish Biotech Gets $5M as Antibody-Antibiotic Combo Enters Phase Ib

A Phase Ib trial will assess the capacity of Symphogen’s antibody to direct an antibiotic to Staphylococcus infections for their effective treatment. Symphogen focuses on the development of antibodies for…

November 30, 2017 - 2 minutesmins - By Alex Dale

News and Trends 7 May 2025

Top biotech deals of April 2025

…company will be centered on. Furthermore, U.K.-based Epsilogen’s takeover of Massachusetts-based TigaTx will combine IgA antibody assets to pioneer new antibody therapeutics to address cancer. The acquisition is bound to…

May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 23 Feb 2017

In the Age of Biological Therapeutics, Chemists move to ADCs

…ADCs include the absence of data on unconjugated antibody testing, criteria for an acceptable amount of unconjugated antibody, and data relating to the drug-antibody ratio. Images from the author …

February 23, 2017 - 4 minutesmins - By Evelyn Warner

More News! 20 Sep 2017

New UK Team will develop Next-Generation Antibody-Drug Conjugates for Cancer

Glythera and IONTAS have partnered to develop next-generation antibody-drug conjugates that are less toxic and more potent against difficult-to-treat tumors. Glythera has teamed up with antibody developer IONTAS to work…

September 20, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 31 Oct 2016

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

…the availability of a wide range of treatments, new agents are still needed to address unmet patient needs including failure to respond to therapy“ Sarilumab is a humanized monoclonal anti-body…

October 31, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 27 Jan 2023

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

…the result of a strategic research alliance between BioArctic and Eisai. Lecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid-beta…

January 27, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Sanofi Obtains License for French Company’s Antibody Engineering Platform

German Biotech Teams Up with BioNTech to Boost Antibody Development

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

The future of NSCLC treatment: what’s in store for the therapeutic space?

New COVID antibody cocktail developed

ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV

Cha-Ching! Danish Biotech Gets $5M as Antibody-Antibiotic Combo Enters Phase Ib

Top biotech deals of April 2025

In the Age of Biological Therapeutics, Chemists move to ADCs

New UK Team will develop Next-Generation Antibody-Drug Conjugates for Cancer

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!